Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells

Ugur Uslu, Stefan Schliep, Klaus Schliep, Michael Erdmann, Hans-Uwe Koch, Hans Parsch, Stina Rosenheinrich, Doris Anzengruber, Anja Katrin Bosserhoff, Gerold Schuler, Beatrice Schuler-Thurner

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells'. Together they form a unique fingerprint.

Medicine & Life Sciences